• Login
    View Item 
    •   ORKA Home
    • Conditions, Lifestyle Factors & Interventions
    • Conditions
    • Substance Use Disorders
    • View Item
    •   ORKA Home
    • Conditions, Lifestyle Factors & Interventions
    • Conditions
    • Substance Use Disorders
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    COVID-19 and substance use disorders: a review of international guidelines for frontline healthcare workers of addiction services

    Thumbnail
    View/Open
    Main article (917.8Kb)
    Date
    2022-03
    Author
    Ostinelli, Edoardo
    Smith, Katharine A
    Zangani, Caroline
    Macdonald, Orla
    Cipriani, Andrea
    Metadata
    Show full item record
    Citation
    Ostinelli, E.G., Smith, K., Zangani, C. , Michael J. Ostacher, Anne R. Lingford-Hughes, James S. W. Hong, Orla Macdonald & Andrea Cipriani . COVID-19 and substance use disorders: a review of international guidelines for frontline healthcare workers of addiction services. BMC Psychiatry 22, 228 (2022).
    Abstract
    People with substance use disorders may be at a greater risk of contracting COVID-19 infection and developing medical complications. Several institutional and governmental health agencies across the world developed ad hoc guidance for substance use disorder services and care of individuals misusing substances. We aimed to synthesise the best available recommendations on management and care of people with or at risk of substance use disorders during the COVID-19 pandemic from existing guidelines published in UK, USA, Australia, Canada, New Zealand, and Singapore. Methods We systematically searched existing guidelines and websites from 28 international institutions and governmental bodies in the context of the COVID-19 pandemic (May 4th 2021). We summarized the extracted data as answers to specific clinical questions. Results We organised the available recommendations from 19 sources in three sections. First, we focused on general advice and recommendations for people who misuse alcohol or drugs during the COVID-19 pandemic, the design of contingency plans, safeguarding issues for children and families of service users and advice to the public, patients, and carers. Then, we summarised specific guidelines for people who use illicit drugs and related services, such as opioid substitution treatment and needle and syringe programmes. Finally, we provided a synthesis on specific recommendations for services supporting people who misuse alcohol and key topics in the field, such as management of alcohol detoxification and safe transition between supervised and unsupervised consumption. Conclusions Available guidance reflected different approaches, ranging from being extremely cautious in providing recommendations other than generic statements to proposing adaptation of previously available guidelines to confront the challenges of the COVID-19 pandemic. After the early phase, guidance focused on reduction of infection transmission and service delivery. Guidance did not provide advice on infection prevention via vaccination programmes and service access strategies tailored to individuals with substance use disorders.
    Description
    Open Access
    URI
    https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/1088
    Published online at:
    https://doi.org/10.1186/s12888-022-03804-7
    Collections
    • Substance Use Disorders [11]

    Oxford Health copyright © 2019
    Contact Us | Send Feedback | JSPUI
    Powered by KnowledgeArc
     

     

    Browse

    All of ORKACommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsContributor DisciplineThis CollectionBy Issue DateAuthorsTitlesSubjectsContributor Discipline

    My Account

    Login

    Researcher Profiles

    Researchers

    Oxford Health copyright © 2019
    Contact Us | Send Feedback | JSPUI
    Powered by KnowledgeArc